Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens

Peer Review reports

Original Submission
20 Feb 2020	Submitted	Original manuscript
24 Mar 2020	Reviewed	Reviewer Report
3 Apr 2020	Reviewed	Reviewer Report - Maria Diab
6 May 2020	Author responded	Author comments - Zev Aryeh Wainberg
Resubmission - Version 2
6 May 2020	Submitted	Manuscript version 2
20 May 2020	Reviewed	Reviewer Report
23 Jun 2020	Author responded	Author comments - Zev Aryeh Wainberg
Resubmission - Version 3
23 Jun 2020	Submitted	Manuscript version 3
Publishing
25 Jun 2020	Editorially accepted
8 Jul 2020	Article published	10.1186/s12885-020-07110-x

Back to article page